Canvuparatide not checked

MBX Biosciences · MBX 2109 · of MBX 2109 - by

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
2 active
5 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“• Drug per vial: Each DDC contains 1 vial of lyophilized drug product. The reconstituted strengths are 400 μg/mL, 600 μg/mL, 800 μg/mL, 1000 μg/mL, 1200 μg/mL, 1400 μg/mL, and 1600 μg/mL.”In the company’s words, NCT07699471 on ClinicalTrials.gov
Tested for
Hypoparathyroidism (2 trials)
Main trialPhase 3
“The purpose of this study is to investigate the efficacy and safety of canvuparatide administered as a once-weekly (QW) treatment to adult study participants with hypoparathyroidism (HypoPT).”In the company’s words, NCT07699471 on ClinicalTrials.gov
Other names
MBX 2109 · of MBX 2109 - by

Other drugs for Hypoparathyroidism

All 6 drugs for Hypoparathyroidism

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials5

TrialPhaseCompletesWhat it tests
Phase 3Recruiting Jan 2028 A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism
Phase 2Active, not recruiting May 2028 Extension Study to Evaluate the Long-Term Safety and Tolerability of MBX 2109 in Patients With Hypoparathyroidism
Phase 2Completed 23 May 2025 Safety, Pharmacokinetics and Efficacy of MBX 2109 in Patients With Hypoparathyroidism
Phase 1Completed 20 Jun 2023 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of MBX 2109 in Healthy Adult Subjects
Phase 1Completed 4 Sep 2025 Safety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Canvuparatide

Following is part of Solo: you see every change to Canvuparatide the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in